Orexigen Therapeutics, Inc. OREX
On a day like yesterday, when the markets take an unexpected and brutal bath, it always helps to find a trend-bucker. Fortunately for us, all was not lost because we had included OREX on our watchlist in our premarket report.
Even as most other stocks wavered under the intensity of yesterdays bearish push, OREX ran from a daily low of .23 to a high of .39 for a 70% intraday run. It also closed with strength at .34, not too far below the area of a massive gap on the chart. We’ll definitely want to continue monitoring OREX, as even a partial filling of said gap would produce further gains of a significant magnitude.
While we’re on the subject of bottom plays, we’re going to add both of the following to our working watchlist, as each one is extraordinarily oversold at the present time.
ReShape Life Sciences, Inc. RSLS
MoneyGram, International, Inc. MGI
AMPE, DFFN, CGEN, VATE, PLPL, CANB